Reviva Pharmaceuticals (RVPH)
(Delayed Data from NSDQ)
$1.67 USD
-0.04 (-2.34%)
Updated May 17, 2024 04:00 PM ET
After-Market: $1.67 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 8/12/24 |
---|---|
Current Quarter | -0.22 |
EPS Last Quarter | -0.25 |
Last EPS Surprise | 10.71% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.93 |
Next Year | -0.93 |
EPS (TTM) | -1.59 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.22 | -0.24 | -0.93 | -0.93 |
# of Estimates | 1 | 1 | 2 | 2 |
Most Recent Consensus | NA | -0.24 | -1.04 | -1.09 |
High Estimate | -0.22 | -0.24 | -0.82 | -0.76 |
Low Estimate | -0.22 | -0.24 | -1.04 | -1.09 |
Year ago EPS | -0.55 | -0.44 | -1.65 | -0.93 |
Year over Year Growth Est. | 60.00% | 45.45% | 43.64% | 0.54% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 1 | 0 |
Down Last 60 Days | 0 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.22 | -0.24 | -0.93 | -0.93 |
7 Days Ago | -0.22 | -0.24 | -0.93 | -0.93 |
30 Days Ago | -0.22 | -0.23 | -0.92 | -0.76 |
60 Days Ago | -0.22 | -0.23 | -0.92 | -0.76 |
90 Days Ago | -0.22 | -0.23 | -0.92 | -0.76 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.22 | -0.24 | -1.04 | -1.09 |
Zacks Consensus Estimate | -0.22 | -0.24 | -0.93 | -0.93 |
Earnings ESP | 0.00% | 0.00% | -11.83% | -17.84% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.25 | -0.35 | -0.44 | -0.55 | NA |
Estimate | -0.28 | NA | -0.35 | -0.29 | NA |
Difference | 0.03 | NA | -0.09 | -0.26 | -0.11 |
Surprise | 10.71% | NA | -25.71% | -89.66% | -34.89% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more